화학공학소재연구정보센터
Macromolecular Research, Vol.23, No.5, 485-492, May, 2015
Dexamethasone phosphate-loaded folate-conjugated polymeric nanoparticles for selective delivery to activated macrophages and suppression of inflammatory responses
E-mail:
Activated macrophages play a central role in the pathology of inflammatory diseases by secreting pro-inflammatory cytokines. In this study, we have developed folate-conjugated dexamethasone phosphate (DP)-loaded poly(D,L-lactic-co-glycolic acid) (PLGA) nanoparticles (NP) that can selectively target to activated macrophages for alleviation of inflammatory responses. DP was loaded into PLGA nanoparticles in an amorphous form using an ionic interaction between DP, zinc, and PLGA. Folic acid (FA) was used as a targeting ligand for activated macrophages and conjugated onto DPNPs (FA-DPNPs). The mean particle size of DPNPs and FA-DPNPs was 126±36 and 133±28 nm, respectively. The zeta potential of DPNPs and FA-DPNPs were ?13.5±0.4 mV and ?14.9±0.9 mV, respectively. Sustained and controlled DP release over 48 hours from DPNPs and FA-DPNPs was observed. The low cellular uptake of both DPNPs and FA-DPNPs was observed in normal RAW264.7 macrophages, whereas significantly higher cellular uptake of FA-DPNPs was observed as compared to DPNPs in activated RAW264.7 macrophages. The production of pro-inflammatory cytokines (IL-6 and TNF-α) and nitric oxide (NO) from activated macrophages was inhibited more significantly by FA-DPNPs than by free DP and DPNPs. Taken together, DP-loaded nanoparticles, especially when conjugated with FA, were selectively internalized by activated macrophages and effectively suppressed inflammatory responses. DP loaded folate-conjugated PLGA nanoparticles presented in this study may offer a promising approach of targeted delivery to activated macrophages for the treatment of inflammatory diseases.
  1. Laskin DL, Pendino KJ, Annu. Rev. Pharmacol. Toxicol., 35, 655 (1995)
  2. Park YD, Jin CH, Choi DS, Byun MW, Jeong IY, Arch. Pharm. Res., 34, 1277 (2011)
  3. Hasturk H, Kantarci A, Dyke TEV, Front. Immunol., 3, 118 (2012)
  4. Hristodorov D, Mladenov R, Huhn M, Barth S, Thepen T, Toxins, 4, 676 (2012)
  5. Martinez FO, Gordon S, F1000Prime Rep., 6 (2014)
  6. Lawrence T, Gilroy DW, Colville-Nash PR, Willoughby DA, Nat. Med., 7, 1291 (2001)
  7. Wynn TA, Chawla A, Pollard JW, Nature, 496(7446), 445 (2013)
  8. Barnes PJ, Clin. Sci., 94, 557 (1998)
  9. Hofkens W, Storm G, Berg WVD, Lent PV, Ann. Rheum. Dis., 70, A40 (2011)
  10. Barnes PJ, Immunol. Allerg. Clin. North Am., 25, 451 (2005)
  11. Saag KG, Curr. Rheumatol. Rep., 4, 218 (2002)
  12. Malam Y, Loizidou M, Seifalian AM, Trends Pharmacol. Sci., 30, 592 (2009)
  13. Ishihara T, Kubota T, Choi T, Higaki M, J. Pharmacol. Exp. Ther., 329, 412 (2009)
  14. Crielaard B, Lammers T, Morgan M, Chaabane L, Carboni S, Greco B, Zaratin P, Kraneveld A, Storm G, Int. J. Pharm., 416, 499 (2011)
  15. Metselaar JM, Wauben MH, Wagenaar-Hilbers J, Boerman OC, Storm G, Arthritis Care Res., 48, 2059 (2003)
  16. Hwang J, Rodgers K, Oliver JC, Schluep T, Int. J. Nanomed., 3, 359 (2008)
  17. Low PS, Antony AC, Adv. Drug Deliv. Rev., 56, 1055 (2004)
  18. Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS, Arthritis Res. Ther., 8, R77 (2006)
  19. Muller C, Schibli R, Front. Oncol., 3 (2013)
  20. Paulos CM, Turk MJ, Breur GJ, Low PS, Adv. Drug Deliv. Rev., 56, 1205 (2004)
  21. Choi JS, Seo K, Yoo JW, J. Pharm. Investig., 42, 155 (2012)
  22. Ishihara T, Takahashi M, Higaki M, Mizushima Y, Int. J. Pharm., 365, 200 (2009)
  23. Stella B, Arpicco S, Peracchia MT, Desmaele D, Hoebeke J, Renoir M, D'Angelo J, Cattel L, Couvreur P, J. Pharm. Sci., 89, 1452 (2000)
  24. Katakam P, Sireesha KR, J. Chem., 9, 1077 (2012)
  25. Gomez-Gaete C, Tsapis N, Besnard M, Bochot A, Fattal E, Int. J. Pharm., 331, 153 (2007)
  26. Keegan ME, Falcone JL, Leung TC, Saltzman WM, Macromolecules, 37(26), 9779 (2004)
  27. Kozak D, Anderson W, Vogel R, Chen S, Antaw F, Trau M, ACS Nano, 6, 6990 (2012)
  28. Musumeci T, Ventura CA, Giannone I, Ruozi B, Montenegro L, Pignatello R, Puglisi G, Int. J. Pharm., 325, 172 (2006)
  29. Bhardwaj U, Burgess DJ, Int. J. Pharm., 388, 181 (2010)
  30. Kim DH, Chung JH, Yoon JS, Ha YM, Bae S, Lee EK, Jung KJ, Kim MS, Kim YJ, Kim MK, J. Ginseng Res., 37, 54 (2013)
  31. Feng D, Ling WH, Duan RD, Inflamm. Res., 59, 115 (2010)
  32. Tabata Y, Ikada Y, Biomaterials, 9, 356 (1988)
  33. Champion JA, Walker A, Mitragotri S, Pharm. Res., 25, 1815 (2008)
  34. Choi JS, Cao J, Naeem M, Noh J, Hasan N, Choi HK, Yoo JW, Colloids Surf. B: Biointerfaces, 122, 545 (2014)
  35. Bamrungsap S, Zhao Z, Chen T, Wang L, Li C, Fu T, Tan W, Nanomedicine, 7, 1253 (2012)
  36. Guzik T, Korbut R, Adamek-Guzik T, J. Physiol. Pharmacol., 54, 469 (2003)
  37. Ishihara K, Hirano T, Cytokine Growth Factor Rev., 13, 357 (2002)
  38. Epstein FH, Gabay C, Kushner I, Engl N, J. Med., 340, 448 (1999)